4baseCare, a precision oncology company focused on building population-relevant clinico-genomic intelligence, has raised an additional Rs 38 crore led by growX ventures and existing investors, as part of its extended Series B funding round. This top-up round has brought 4baseCare’s total Series B raise to Rs 128 crore, says a company statement. Earlier this year, the company had announced a raise of Rs 90 crore in its Series B round, co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing backer Yali Capital. The company is expanding its hospital-linked genomics laboratory network across India, southeast Asia, Latin America, and central Asia, to improve access to advanced genomic testing and precision cancer care.Ready to Make a Smarter Property Decision? Build Your Legacy with TOI Homes.